KONFIDENT-S Interim Analysis: Sebetralstat for Hereditary Angioedema Attacks (Including Laryngeal)

Farkas H

Bradykinin Symposium 2024

Delayed On-demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported by Italian Patients

Cancian M

Bradykinin Symposium 2024

A Specific, Sensitivity Assay Measuring Patient Sample Plasma Kallikrein Activity

Lee D

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Safety for On-demand Treatment of Hereditary Angioedema (Oral Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Efficacy for On-demand Treatment of Hereditary Angioedema (Poster Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment

Jones D, Buttgereit T, Carne E, Cohn D

EAACI 2024

Sebetralstat KONFIDENT Is the First Phase 3 On-demand HAE Trial to Include Japanese Sites

Honda D, Hide M,2 Ohsawa I, Watanabe Y, Hao J, Smith MD, Yea CM, Audhya PK, Riedl MA, Cohn DM
Japanese Dermatological Association

Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S

Henriette Farkas, Marc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn
EAACI 2024

Hereditary Angioedema (HAE) Patients Answer: Why Do Attacks Go Untreated?

Radojicic C, Busse P, O’Connor M, Danese S, Ulloa J, Desai V, Andriotti T, Audhya PK, Christiansen S
EAACI 2024

Attack Characteristics in Patients with Hereditary Angioedema Receiving Non-Androgen Long-term Prophylaxis

Lumry W, Baptist A, Soteres D, Manning M, Earl L, Connolly H, Audhya PK, Wang A, Andriotti T, Desai V
EAACI 2024